secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001193125-23-167882
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte stockholders re-elect three Class III directors, ratify Deloitte, approve say-on-pay
--------------------------------------------------------------------------------

- Class III directors Halley Gilbert, Michael Kamarck, and Grant Pickering re-elected with over 61M votes each.
- Ratification of Deloitte & Touche as independent auditor for FY2023 approved with 74.9M for, 3,583 against.
- Non-binding advisory vote on named executive officer compensation approved with 62.9M for, 7.2M against.
- Broker non-votes were 4,802,816 on director election and say-on-pay matters.
- All three proposals passed as recommended by the board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312523167882/0001193125-23-167882-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312523167882/d456008d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-167882

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer